Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

Autor: Micallef IN; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Stiff PJ; Division of Hematology/Oncology, Loyola University, Chicago, Illinois., Nademanee AP; City of Hope Comprehensive Cancer Center, Duarte, California., Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina., Stadtmauer EA; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Kaufman JL; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia., McCarty JM; Department of Internal Medicine, Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia., Vargo R; Sanofi, Cambridge, Massachusetts., Cheverton PD; Sanofi, Cambridge, Massachusetts., Struijs M; Sanofi, Naarden, The Netherlands., Bolwell B; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., DiPersio JF; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: jdipersi@wustl.edu.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 Jun; Vol. 24 (6), pp. 1187-1195. Date of Electronic Publication: 2018 Feb 02.